Regulus Therapeutics
RGLS
#8863
Rank
C$0.14 B
Marketcap
$2.28
Share price
2.58%
Change (1 day)
38.69%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of September 2024 : C$0.12 Billion

According to Regulus Therapeutics's latest financial reports the company has C$0.12 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31C$53.13 M-30.95%
2021-12-31C$76.95 M94.14%
2020-12-31C$39.63 M-11.05%
2019-12-31C$44.56 M134.77%
2018-12-31C$18.98 M-74.87%
2017-12-31C$75.52 M-26.16%
2016-12-31C$0.10 B-35.36%
2015-12-31C$0.15 B-14.65%
2014-12-31C$0.18 B52.75%
2013-12-31C$0.12 B24.41%
2012-12-31C$97.55 M151.42%
2011-12-31C$38.8 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$6.17 B 4,823.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$10.46 B 8,242.93%๐Ÿ‡ซ๐Ÿ‡ท France
C$2.44 B 1,846.19%๐Ÿ‡บ๐Ÿ‡ธ USA
C$7.08 B 5,546.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$3.99 B 3,084.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$56.32 M-55.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$11.62 B 9,170.52%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA